Evidence map›Paper›PMID 36163498›Full record

ArticleNature microbiology2022

Strain-specific impacts of probiotics are a significant driver of gut microbiome development in very preterm infants.

Lauren C Beck, Andrea C Masi, Gregory R Young, Tommi Vatanen, Christopher A Lamb, Rachel Smith, Jonathan Coxhead, Alana Butler, Benjamin J Marsland, Nicholas D Embleton and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Nature microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed, 3 pooled it
12.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 3 syntheses or guidelines pooled it, 154 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Observational
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 4 countries.

Lauren C BeckTranslational and Clinical Research Institute, Newcastle University, Newcastle, UK.
Andrea C MasiTranslational and Clinical Research Institute, Newcastle University, Newcastle, UK.
Gregory R YoungHub for Biotechnology in the Built Environment, Northumbria University, Newcastle, UK.ORCID http://orcid.org/0000-0001-5342-1421
Tommi VatanenLiggins Institute, University of Auckland, Auckland, New Zealand.
Christopher A LambTranslational and Clinical Research Institute, Newcastle University, Newcastle, UK.ORCID http://orcid.org/0000-0002-7271-4956
Rachel SmithBioscience Institute, Newcastle University, Newcastle, UK.ORCID http://orcid.org/0000-0001-8104-3720
Jonathan CoxheadBioscience Institute, Newcastle University, Newcastle, UK.
Alana ButlerDepartment of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
Benjamin J MarslandDepartment of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0003-1457-3160
Nicholas D EmbletonNewcastle Neonatal Service, Newcastle Hospitals NHS Trust, Newcastle, UK.
Janet E BerringtonTranslational and Clinical Research Institute, Newcastle University, Newcastle, UK. j.e.berrington@ncl.ac.uk.ORCID http://orcid.org/0000-0002-6185-2843
Christopher J StewartTranslational and Clinical Research Institute, Newcastle University, Newcastle, UK. christopher.stewart@newcastle.ac.uk.ORCID http://orcid.org/0000-0002-6033-338X
Newcastle University · GBMonash University · AUBroad Institute · USNewcastle College · GBNewcastle upon Tyne Hospitals NHS Foundation Trust · GBNorthumbria University · GB

Funding

Wellcome Trust 221745
6 · The paper itself

Abstract

The development of the gut microbiome from birth plays important roles in short- and long-term health, but factors influencing preterm gut microbiome development are poorly understood. In the present study, we use metagenomic sequencing to analyse 1,431 longitudinal stool samples from 123 very preterm infants (<32 weeks' gestation) who did not develop intestinal disease or sepsis over a study period of 10 years. During the study period, one cohort had no probiotic exposure whereas two cohorts were given different probiotic products: Infloran (Bifidobacterium bifidum and Lactobacillus acidophilus) or Labinic (B. bifidum, B. longum subsp. infantis and L. acidophilus). Mothers' own milk, breast milk fortifier, antibiotics and probiotics were significantly associated with the gut microbiome, with probiotics being the most significant factor. Probiotics drove microbiome transition into different preterm gut community types (PGCTs), each enriched in a different Bifidobacterium sp. and significantly associated with increased postnatal age. Functional analyses identified stool metabolites associated with PGCTs and, in preterm-derived organoids, sterile faecal supernatants impacted intestinal, organoid monolayer, gene expression in a PGCT-specific manner. The present study identifies specific influencers of gut microbiome development in very preterm infants, some of which overlap with those impacting term infants. The results highlight the importance of strain-specific differences in probiotic products and their impact on host interactions in the preterm gut.

Indexed as

Bifidobacterium bifidumGastrointestinal MicrobiomeProbioticsAnti-Bacterial AgentsBifidobacteriumFemaleHumansInfantInfant, NewbornInfant, PrematureAnti-Bacterial Agents

Identifiers

PMID36163498
PMCPMC9519454
OpenAlexW4297243178

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.